TSJCI Annual Report 2021

Trinity St James’s Cancer Institute Annual Report 2021 6 Trinity St James’s Cancer Institute Governance Structure The TSJCI Programme Office provides the support and oversight for TSJCI’s multiple streams of work, building on the recommendations and quality improvement plan following the Organisation of European Cancer Institutes (OECI) Cancer Centre accreditation and designation award in 2019. These prioritised work streams are helping us prepare for re accreditation in 2024 with the aim of achieving Comprehensive Cancer Centre designation. The appointment of the Medical and Academic Directors and the signing of the Memorandum of Understanding (MOU) with TCD and SJH in June 2021, were significant milestones for TSJCI, bringing us a step closer to realising our ambition. The TSJCI Executive Committee, under the leadership of the joint directors held its first meeting in July 2021. The committee has a broad membership with representation from all relevant TSJCI stakeholders. The TSJCI Governance Board was also appointed in 2021 with the first meeting scheduled for January 2022, and will be chaired by an external chairperson, Mr. Dermot McCarthy. The TSJCI External Advisory Board (EAB) membership was agreed in 2021, and will meet virtually initially in 2022, and in person at the 12 th International Cancer Conference in October 2022. The EAB has excellent representation from leaders in their fields providing scientific, medical, educational, managerial, nursing and patient representation. Figure 1: TSJCI Governance Structure TSJCI Governance Board TSJCI Executive Committee TSJCI Programme Office TSJCI External Advisory Board SJH Board TCD Board